Verrica Pharmaceuticals annual operating margin
2021
2022
2023
2024
2025
Verrica Pharmaceuticals's operating margin was −34.25% for fiscal 2025.
View full Verrica Pharmaceuticals company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −34.25% | +837.00 pp |
| 2024 | 2024-12-31 | −871.25% | +412.10 pp |
| 2023 | 2023-12-31 | −1,283.35% | −1047.57 pp |
| 2022 | 2022-12-31 | −235.78% | +21.78 pp |
| 2021 | 2021-12-31 | −257.57% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −223.42% | −235.31 pp |
| Q1 2026 | 2026-03-31 | −193.41% | +43.00 pp |
| Q4 2025 | 2025-12-31 | −141.24% | +3175.62 pp |
| Q3 2025 | 2025-09-30 | 11.34% | +305.06 pp |
| Q2 2025 | 2025-06-30 | 11.89% | +498.01 pp |
| Q1 2025 | 2025-03-31 | −236.41% | +927.43 pp |
| Q4 2024 | 2024-12-31 | −3,316.86% | −2496.94 pp |
| Q2 2024 | 2024-06-30 | −293.72% | +6088.70 pp |
| Q1 2024 | 2024-03-31 | −486.12% | +18673.34 pp |
| Q4 2023 | 2023-12-31 | −1,163.83% | +7972.93 pp |
| Q3 2023 | 2023-09-30 | −819.92% | −837.32 pp |
| Q2 2023 | 2023-06-30 | −6,382.42% | −2120.27 pp |
| Q1 2023 | 2023-03-31 | −19,159.46% | −17440.20 pp |
| Q4 2022 | 2022-12-31 | −9,136.76% | −9137.26 pp |
| Q3 2022 | 2022-09-30 | 17.41% | — |
| Q2 2022 | 2022-06-30 | −4,262.15% | — |
| Q1 2022 | 2022-03-31 | −1,719.26% | — |
| Q1 2021 | 2021-03-31 | 0.50% | — |
Across the available reported history, Verrica Pharmaceuticals's operating margin increased from −871.25% to −34.25%, a change of +837.00 percentage points. The latest reported quarter, Q2 2026, shows −223.42%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Verrica Pharmaceuticals filings at SEC.gov ↗